gucy2c cart cells

BIOLOGICAL2 trials

Sponsors

Weijia Fang, MD, Innovative Cellular Therapeutics Co., Ltd.

Conditions

Malignant Neoplasms of Digestive Organs

Early Phase 1

CART Therapy in GUCY2C-positive Digestive Tract Tumors

CompletedNCT04652219

Weijia Fang, MDMalignant Neoplasms of Digestive Organs

Start: 2020-10-10End: 2021-10-09Updated: 2023-07-17

Unknown Phase

CART Therapy in Digestive System Tumors

Not yet recruitingNCT04780529

Innovative Cellular Therapeutics Co., Ltd.Malignant Neoplasms of Digestive Organs

Start: 2021-03-31End: 2026-03-31Target: 20Updated: 2021-03-03